Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients

American Journal of Emergency Medicine

Volumn 30, Issue 9, 2012, Pages 1915-1920

  Cinar, Orhan ^a   Cevik, Erdem ^a   Acar, Ayhan ^a   Kaya, Cengiz ^a   Ardic, Sukru ^a   Comert, Bilgin ^a   Yokusoglu, Mehmet ^a   Bilgi, Cumhur ^a   Meisner, Michael ^b   Madsen, Troy ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GATA Kardiyoloji Anabilim DalI ^*  (Germany)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; PROADRENOMEDULLIN; PROATRIAL NATRIURETIC FACTOR; PROCALCITONIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DYSPNEA; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 84869160281     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2012.04.009     Document Type: Article

References (21)

1. E.W. Nawar, R.W. Niska, and J. Xu National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary Adv Data 386 2007 1 32
2. S.M. Green, A. Martinez-Rumayor, and S.A. Gregory Clinical uncertainty, diagnostic accuracy, and outcomes in emergency department patients presenting with dyspnea Arch Intern Med 168 2008 741 748
3. C.P. Wills, M. Young, and D.W. White Pitfalls in the evaluation of shortness of breath Emerg Med Clin North Am 28 2010 163 181
4. M. Lainscak, S. Von Haehling, and S.D. Anker Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers Int J Cardiol 132 2009 303 311
5. A. Gegenhuber, J. Struck, and W. Poelz Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP Clin Chem 52 2006 827 831
6. A. Maisel, C. Mueller, and R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
7. D. Stolz, M. Christ-Crain, and R. Bingisser Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy Chest 131 2007 9 19
8. P. Schuetz, M. Christ-Crain, and R. Thomann Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA 302 2009 1059 1066
9. K. Kitamura, K. Kangawa, and M. Kawamoto Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma Biochem Biophys Res Commun 192 1993 553 560
10. M. Potocki, T. Breidthardt, and T. Reichlin Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study Crit Care 13 2009 R122
11. D.T. Huang, D.C. Angus, and J.A. Kellum Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 2009 823 831
12. S.P. Collins, S. Ronan-Bentle, and A.B. Storrow Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea Ann Emerg Med 41 2003 532 545
13. P.A. McCullough, R.M. Nowak, and J. McCord B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study Circulation 106 2002 416 422
14. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
15. S.M. Silvers, J.M. Howell, and J.M. Kosowsky Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes Ann Emerg Med 49 2007 627 669
16. B. Muller, S. Harbarth, and D. Stolz Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia BMC Infect Dis 7 2007 10
17. D. Stolz, M. Christ-Crain, and N.G. Morgenthaler Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD Chest 131 2007 1058 1067
18. M. Christ-Crain, N.G. Morgenthaler, and D. Stolz Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] Crit Care 10 2006 R96
19. D. Stolz, M. Christ-Crain, and N.G. Morgenthaler Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD Chest 134 2008 263 272
20. M. Christ-Crain, N.G. Morgenthaler, and J. Struck Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 9 2005 R816 R824
21. A. Gegenhuber, J. Struck, and B. Dieplinger Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure J Card Fail 13 2007 42 49